Page 231 - Vitamin D and Cancer

218 F.S.G. Cheung and J.K.V. Reichardt

118. Ohyama Y, Ozono K, Uchida M et al (1996) Functional assessment of two vitamin
D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase gene. J Biol Chem
271(48):30381–30385
119. Oliveria SA, Saraiya M, Geller AC et al (2006) Sun exposure and risk of melanoma. Arch
Dis Child 91(2):131–138
120. Panda DK, Miao D, Bolivar I et al (2004) Inactivation of the 25-hydroxyvitamin D 1alpha-hy-
droxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium
and vitamin D on skeletal and mineral homeostasis. J Biol Chem 279(16):16754–16766
121. Peehl DM, Skowronski RJ, Leung GK et al (1994) Antiproliferative effects of 1, 25-
dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res 54(3):805–810
122. Perez AV, Picotto G, Carpentieri AR et al (2008) Minireview on regulation of intestinal calcium
absorption. Emphasis on molecular mechanisms of transcellular pathway. Digestion 77(1):22–34
123. Peterson CL, Logie C (2000) Recruitment of chromatin remodeling machines. J Cell
Biochem 78(2):179–185
124. Pillai S, Bikle DD, Elias PM (1988) 1, 25-Dihydroxyvitamin D production and receptor bind-
ing in human keratinocytes varies with differentiation. J Biol Chem 263(11):5390–5395
125. Plotnikoff GA, Quigley JM (2003) Prevalence of severe hypovitaminosis D in patients with
persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 78(12):1463–1470
126. Polednak AP (1984) Seasonal patterns in the diagnosis of malignant melanoma of skin and
eye in upstate New York. Cancer 54(11):2587–2594
127. Posner GH, Jeon HB, Sarjeant A et al (2004) Low-calcemic, efficacious, 1alpha, 25-
dihydroxyvitamin D3 analog QW-1624F2–2: calcemic dose-response determination, preclinical
genotoxicity testing, and revision of A-ring stereochemistry. Steroids 69(11–12):757–762
128. Querings K, Girndt M, Geisel J et al (2006) 25-hydroxyvitamin D deficiency in renal trans-
plant recipients. J Clin Endocrinol Metab 91(2):526–529
129. Querings K, Reichrath J (2004) A plea for the analysis of Vitamin-D levels in patients under
photoprotection, including patients with xeroderma pigmentosum (XP) and basal cell nevus
syndrome (BCNS). Cancer Causes Control 15(2):219
130. Rass K, Reichrath J (2008) UV damage and DNA repair in malignant melanoma and non-
melanoma skin cancer. Adv Exp Med Biol 624:162–178
131. Ratnam AV, Bikle DD, Cho JK (1999) 1, 25 dihydroxyvitamin D3 enhances the calcium
response of keratinocytes. J Cell Physiol 178(2):188–196
132. Ravanat JL, Douki T, Cadet J (2001) Direct and indirect effects of UV radiation on DNA and
its components. J Photochem Photobiol B 63(1–3):88–102
133. Reichrath J (2006) The challenge resulting from positive and negative effects of sunlight:
how much solar UV exposure is appropriate to balance between risks of vitamin D defi-
ciency and skin cancer? Prog Biophys Mol Biol 92(1):9–16
134. Ross MH, Kaye GI, Pawlina W (2003) Histology: a text and atlas, 4th edn. Lippincott
Williams & Wilkins, Philadelphia
135. Sambrook P (2005) Vitamin D and fractures: quo vadis? Lancet 365(9471):1599–1600
136. Schwartz SM, Armstrong BK, Weiss NS (1987) Seasonal variation in the incidence of cuta-
neous malignant melanoma: an analysis by body site and histologic type. Am J Epidemiol
126(1):104–111
137. Scotto J, Nam JM (1980) Skin melanoma and seasonal patterns. Am J Epidemiol
111(3):309–314
138. Sebag M, Henderson J, Rhim J et al (1992) Relative resistance to 1, 25-dihydroxyvitamin D3
in a keratinocyte model of tumor progression. J Biol Chem 267(17):12162–12167
139. Segaert S, Garmyn M, Degreef H et al (1997) Retinoic acid modulates the anti-proliferative effect
of 1, 25-dihydroxyvitamin D3 in cultured human epidermal keratinocytes. J Invest Dermatol
109(1):46–54
140. Setlow RB (1966) Cyclobutane-type pyrimidine dimers in polynucleotides. Science
153(734):379–386
141. Shabahang M, Buras RR, Davoodi F et al (1993) 1, 25-Dihydroxyvitamin D3 receptor as a
marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res
53(16):3712–3718